Register Now
Why register?
 The leading web portal for pharmacy resources, news, education and careers October 22, 2017
Pharmacy Choice - Pharmaceutical News - Recent Findings from University of New Mexico Has Provided New Information about Diabetes (Diabetes and the Affordable Care Act) - October 22, 2017

Pharmacy News Article

 8/4/14 - Recent Findings from University of New Mexico Has Provided New Information about Diabetes (Diabetes and the Affordable Care Act)

By a News Reporter-Staff News Editor at Diabetes Week A new study on Diabetes is now available. According to news reporting from Albuquerque, New Mexico, by NewsRx journalists, research stated, "The Affordable Care Act-'Obamacare''-is the most important federal medical legislation to be enacted since Medicare. Although the goal of the Affordable Care Act is to improve healthcare coverage, access, and quality for all Americans, people with diabetes are especially poised to benefit from the comprehensive reforms included in the act."

The news correspondents obtained a quote from the research from the University of New Mexico, "Signed into law in 2010, this massive legislation will slowly be enacted over the next 10 years. In the making for at least a decade, it will affect every person in the United States, either directly or indirectly. In this review, we discuss the major changes in healthcare that will take place in the next several years, including (1) who needs to purchase insurance on the Web-based exchange, (2) the cost to individuals and the rebates that they may expect, (3) the rules and regulations for purchasing insurance, (4) the characteristics of the different 'metallic'' insurance plans that are available, and (5) the states that have agreed to participate. With both tables and figures, we have tried to make the Affordable Care Act both understandable and appreciated."

According to the news reporters, the research concluded: "The goal of this comprehensive review is to highlight aspects of the Affordable Care Act that are of importance to practitioners who care for people with diabetes by discussing both the positive and the potentially negative aspects of the program as they relate to diabetes care."

For more information on this research see: Diabetes and the Affordable Care Act. Diabetes Technology & Therapeutics, 2014;16(7):399-413. Diabetes Technology & Therapeutics can be contacted at: Mary Ann Liebert, Inc, 140 Huguenot Street, 3RD Fl, New Rochelle, NY 10801, USA. (Mary Ann Liebert, Inc. -; Diabetes Technology & Therapeutics -

Our news journalists report that additional information may be obtained by contacting M.R. Burge, University of New Mexico, Sch Med, Albuquerque, NM 87131, United States (see also Diabetes).

Keywords for this news article include: Diabetes, New Mexico, Albuquerque, Legal Issues, United States, North and Central America

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC

(c) 2014 NewsRx LLC

Pharmacy News Index
  Drug Delivery Systems
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry


Last Chance
Oct 23: Vitamin D Primer for Pharmacy Professionals
Oct 24: Metabolic Syndrome: The Heart of Any Wellness Practice
Oct 25: Dispensing Controlled Substances in Today’s Pharmacy
Oct 26: Management of Schizophrenia & Acute Agitation
Oct 27: Influenza 2017-2018: An Update on Prevention and Treatment
Click for entire Webinar Calendar

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Nursing Jobs
Are you a nurse looking for a job?

Check out the Nursing Job Source.

Your number one choice for nursing jobs.

Websites »
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement